Impact of Tumor-Derived DNA Testing in Peritoneal Lavage of Pancreatic Cancer Patients with and Without Occult Intra-Abdominal Metastases

[1]  M. Ishida,et al.  GNAS mutation detection in circulating cell-free DNA is a specific predictor for intraductal papillary mucinous neoplasms of the pancreas, especially for intestinal subtype , 2020, Scientific Reports.

[2]  F. Sonohara,et al.  Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis , 2020, The British journal of surgery.

[3]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[4]  T. Fujii,et al.  Prognostic importance of peritoneal washing cytology in patients with otherwise resectable pancreatic ductal adenocarcinoma who underwent pancreatectomy: A nationwide, cancer registry-based study from the Japan Pancreas Society. , 2019, Surgery.

[5]  S. Horiguchi,et al.  Utility of liquid biopsy using urine in patients with pancreatic ductal adenocarcinoma , 2019, Cancer biology & therapy.

[6]  S. Knappskog,et al.  Mutation analysis by deep sequencing of pancreatic juice from patients with pancreatic ductal adenocarcinoma , 2019, BMC Cancer.

[7]  Yusuke Takahashi,et al.  Subclinical cancer cell dissemination in peritoneal lavage fluid detected by reverse‐transcription polymerase chain reaction identifies patients at high risk for peritoneal recurrence and consequent impaired survival in the setting of preoperative chemoradiation therapy for pancreatic cancer☆,☆☆,★ , 2018, Surgery.

[8]  I. Endo,et al.  RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence. , 2018, The Journal of surgical research.

[9]  J. Kleeff,et al.  Therapeutic developments in pancreatic cancer: current and future perspectives , 2018, Nature Reviews Gastroenterology & Hepatology.

[10]  K. Jong,et al.  The Additional Value of Laparoscopic Ultrasound to Staging Laparoscopy in Patients with Suspected Pancreatic Head Cancer , 2018, Journal of Gastrointestinal Surgery.

[11]  M. Goggins,et al.  Pancreatic Juice Mutation Concentrations Can Help Predict the Grade of Dysplasia in Patients Undergoing Pancreatic Surveillance , 2018, Clinical Cancer Research.

[12]  Steven J. M. Jones,et al.  Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. , 2017, Cancer cell.

[13]  K. Lillemoe,et al.  Staging Laparoscopy Not Only Saves Patients an Incision, But May Also Help Them Live Longer , 2017, Annals of Surgical Oncology.

[14]  A. Bardelli,et al.  Integrating liquid biopsies into the management of cancer , 2017, Nature Reviews Clinical Oncology.

[15]  S. Yamada,et al.  Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal Metastasis. , 2017, Annals of surgery.

[16]  F. Cao,et al.  Prognostic significance of positive peritoneal cytology in resectable pancreatic cancer: a systemic review and meta-analysis , 2017, Oncotarget.

[17]  Y. Takwoingi,et al.  Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. , 2016, The Cochrane database of systematic reviews.

[18]  M. Ishida,et al.  Telomerase activity in pancreatic juice differentiates pancreatic cancer from chronic pancreatitis: A meta-analysis. , 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[19]  R. Gibbs,et al.  Genomic analyses identify molecular subtypes of pancreatic cancer , 2016, Nature.

[20]  H. Ueno,et al.  Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer , 2015, Scientific Reports.

[21]  B. Stanger,et al.  Pancreatic Cancer Metastases Harbor Evidence of Polyclonality. , 2015, Cancer discovery.

[22]  S. Duffy,et al.  Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma , 2015, Clinical Cancer Research.

[23]  L. Diaz,et al.  Liquid biopsies: genotyping circulating tumor DNA. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  M. Choti,et al.  Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies , 2014, Science Translational Medicine.

[25]  C. Swanton.  Intratumor heterogeneity: evolution through space and time. , 2012, Cancer research.

[26]  D. Ahlquist,et al.  Stool DNA testing for the detection of pancreatic cancer , 2012, Cancer.

[27]  M. Nowak,et al.  Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.

[28]  M. Gonen,et al.  Prognostic Impact of RT-PCR-Based Detection of Peritoneal Micrometastases in Patients with Pancreatic Cancer Undergoing Curative Resection , 2009, Annals of Surgical Oncology.

[29]  Ruud H. Brakenhoff,et al.  Detection, clinical relevance and specific biological properties of disseminating tumour cells , 2008, Nature Reviews Cancer.

[30]  Ying Wang,et al.  Detection of p53 Gene Mutations in the Supernatant of Pancreatic Juice and Plasma from Patients with Pancreatic Carcinomas , 2004, Pancreas.

[31]  T. Okai,et al.  Usefulness of Supernatant of Pancreatic Juice for Genetic Analysis of K-ras in Diagnosis of Pancreatic Carcinoma , 2001, Pancreas.

[32]  I. Okayasu,et al.  k‐ras Point Mutations in the Supernatants of Pancreatic Juice and Bile Are Reliable for Diagnosis of Pancreas and Biliary Tract Carcinomas Complementary to Cytologic Examination , 1999, Japanese journal of cancer research : Gann.

[33]  D. Rattner,et al.  Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer , 1995, The British journal of surgery.

[34]  E. Nakakura,et al.  NCCN GUIDELINES ® INSIGHTS CE Pancreatic Adenocarcinoma , Version 1 . 2019 Featured Updates to the NCCN Guidelines , 2019 .

[35]  G. Honda,et al.  Reappraisal of Peritoneal Washing Cytology in 984 Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Margin-Negative Resection , 2014, Journal of Gastrointestinal Surgery.

[36]  Wolfgang Schima,et al.  Pancreatic adenocarcinoma , 2006, European Radiology.